OCD and Substance Use: What Is the Connection? Alcohol, Drugs, Coping, Comorbidity, and Treatment

1 day ago

19 min read

Updated: 8 hours ago

Author: Ukrainian Psychological Hub · Published: September 15, 2026 · Editorial Policy

Obsessive-compulsive disorder (OCD) and substance use disorders (SUDs) can occur in the same person, and the combination can change how symptoms are recognized, how risk is assessed, and how treatment is planned. Some people use alcohol, cannabis, sedatives, stimulants, opioids, or other substances in an attempt to dampen anxiety, intrusive thoughts, insomnia, shame, or emotional overload. Others develop a substance use disorder through pathways that are only partly related to OCD. The clinically important point is that repeated substance use, craving, and addiction are not simply “OCD compulsions,” even when both conditions involve repetitive behavior.

Research supports a meaningful association between OCD and substance-related problems, but there is no single prevalence figure that applies to everyone. Estimates differ across treatment-seeking samples, community samples, substances, diagnostic definitions, and time periods. In a clinical sample of 323 adults with OCD, 27% met lifetime criteria for a substance use disorder, and 70% of those with a SUD reported that OCD began at least one year earlier (Mancebo et al., 2009). A large Swedish population study later found that diagnosed OCD was associated with an elevated risk of registry-defined substance misuse, with a hazard ratio of 3.68, while analyses of twins and siblings suggested contributions from both shared genetic liability and nonshared environmental factors (Virtanen et al., 2022).

The newest evidence also sharpens the alcohol picture. A 2026 study of 1,222 OCD-affected adults found a 13% lifetime history of DSM-IV alcohol dependence in that research cohort. Alcohol dependence was associated with greater psychiatric comorbidity, a lower likelihood of having received serotonin reuptake inhibitor treatment, and poorer reported medication response among those who had received it (Samuels et al., 2026). These findings do not mean that OCD inevitably leads to addiction. They mean that substance use deserves routine, direct assessment when clinicians evaluate OCD.

OCD and Substance Use: The Short Answer

OCD is characterized by obsessions, compulsions, or both that are time-consuming, distressing, or functionally impairing. Obsessions are intrusive and unwanted thoughts, images, or urges; compulsions are repetitive behaviors or mental acts performed according to rigid rules or in response to obsessions. The National Institute of Mental Health emphasizes that ordinary repeated thoughts and habits do not automatically qualify as obsessions or compulsions.

Substance use exists on a continuum. A person can use alcohol or another drug without having a substance use disorder. A SUD involves a clinically significant pattern of use associated with impaired control, health or social consequences, risky use, tolerance, withdrawal, or related impairment. Screening questions can identify risk, but a screening result is not the same thing as a diagnosis.

When OCD and a SUD occur together, both conditions deserve assessment. Treating one while ignoring the other can leave a major driver of distress, avoidance, relapse, or treatment dropout untouched. The U.S. Substance Abuse and Mental Health Services Administration recommends integrated approaches for co-occurring mental and substance use disorders rather than creating a system in which a person must somehow “finish” one problem before receiving care for the other (SAMHSA, Co-Occurring Disorders).

How Common Are Substance Use Disorders in People With OCD?

The evidence is consistent on one point: co-occurrence is clinically important. The precise frequency remains variable. The 27% lifetime SUD figure from Mancebo and colleagues came from a treatment-seeking OCD sample, so it should not be treated as a universal population prevalence. In that sample, alcohol use disorders were more common than drug use disorders, and OCD usually preceded the reported onset of SUD among people who had both (Mancebo et al., 2009).

Community data complicate any simple “OCD causes addiction” story. A representative Dutch population study of 7,076 adults examined the co-occurrence of OCD and SUD and found that the relationship differed by substance and by comparison disorder (Blom et al., 2011). A later Swedish study using national registers and a separate twin cohort found a robust association between OCD or obsessive-compulsive symptoms and substance misuse or dependence symptoms. Importantly, depression and anxiety did not fully account for that association (Virtanen et al., 2022).

Alcohol-specific studies also show heterogeneity. In a Brazilian clinical sample of 630 people with OCD, 7.5% had current or past alcohol use disorder; that subgroup had more psychiatric comorbidity and more lifetime suicidal thoughts and attempts (Gentil et al., 2009). The larger 2026 OCD cohort reported lifetime alcohol dependence in 13% of participants (Samuels et al., 2026). Differences between 7.5%, 13%, and 27% are not contradictions: the studies measured different outcomes in different populations.

For readers, the practical conclusion is more useful than a single percentage. If a person has OCD, clinicians should ask about alcohol and drug use directly, including why the substance is used, how often, whether control has changed, whether withdrawal occurs, and whether use interferes with treatment or daily life.

Why Can OCD and Substance Use Occur Together?

Coping and Self-Medication

One pathway is negative reinforcement: a substance may temporarily reduce distress, tension, social inhibition, physiological arousal, or awareness of intrusive thoughts. That short-term relief can teach the person to repeat the behavior the next time distress appears. The behavior can become increasingly automatic even if its long-term consequences worsen.

Studies of drinking motives support this pathway without proving that OCD directly causes alcohol misuse. In a college sample, obsessive-compulsive symptoms were associated with problematic alcohol use partly through coping motives (Bakhshaie et al., 2021). A larger 2024 study of U.S. adults also found that coping motives helped explain the relationship between obsessive-compulsive symptoms and alcohol misuse (Randazza et al., 2024). These are association and mediation studies, not experiments establishing a single causal chain.

Shared Vulnerability and Compulsivity

OCD and addictions are both studied within broader models of compulsivity, habit learning, cognitive control, reward, and goal-directed behavior. A review by Cuzen and colleagues proposed compulsivity as a useful heuristic for understanding some of the overlap between OCD and SUD (Cuzen et al., 2014). This is a transdiagnostic model, not a statement that OCD and addiction are the same disorder.

The Swedish longitudinal work adds another layer: family-based analyses suggested that shared genetic factors explained a substantial portion of the covariance between OCD-related phenomena and substance misuse, with nonshared environmental factors accounting for the rest (Virtanen et al., 2022). That supports a vulnerability model broader than simple self-medication.

Other Psychiatric Conditions Can Shape the Relationship

Depression, anxiety disorders, bipolar disorder, ADHD, trauma-related symptoms, personality pathology, and sleep disturbance can influence both substance use and OCD treatment. The presence of another condition may alter the timing and function of drinking or drug use. This is one reason an integrated assessment should look beyond a two-diagnosis checklist.

Within the English Psychology Hub, related guides examine OCD and depression, OCD and anxiety disorders, OCD and bipolar disorder, and OCD and ADHD.

Does Alcohol Help OCD or Make It Worse?

Alcohol can feel helpful in the short term because intoxication may reduce tension, self-monitoring, or awareness of anxiety. A person may therefore learn to drink before a trigger, after an intrusive thought, at bedtime, or after an exhausting period of resisting compulsions. The subjective experience of relief is real, but it does not establish alcohol as an OCD treatment.

Repeated reliance on alcohol can create additional problems: tolerance, escalating use, impaired judgment, disrupted sleep, withdrawal symptoms, depressed mood, interpersonal consequences, missed medication, and avoidance of exposure-based learning. Alcohol can also interact with medications. The National Institute on Alcohol Abuse and Alcoholism documents clinically important alcohol-medication interactions, while NICE OCD guidance specifically advises clinicians evaluating poor SSRI response to check adherence, dose, and whether alcohol or substance use is interfering with treatment (NICE CG31).

Alcohol use may also complicate risk assessment. In the Brazilian OCD sample described above, comorbid alcohol use disorder was associated with more lifetime suicidal thoughts and attempts (Gentil et al., 2009). This association does not mean that alcohol alone caused suicidality, but it supports careful assessment when OCD, alcohol problems, depression, impulsivity, or suicidal thinking occur together.

Alcohol Withdrawal Is a Medical Issue

People who drink heavily or who have developed physiological dependence should not assume that abrupt cessation is always safe. Alcohol withdrawal can include autonomic symptoms, severe agitation, hallucinations, seizures, and delirium in high-risk cases. The American Society of Addiction Medicine guideline treats withdrawal management as a medical process and stresses that withdrawal management itself is only one component of treatment for alcohol use disorder.

If someone has a history of withdrawal seizures, delirium, severe withdrawal, very heavy sustained drinking, major medical illness, pregnancy, or uncertainty about withdrawal risk, medical assessment is appropriate before attempting abrupt cessation.

OCD and Cannabis

Cannabis deserves separate discussion because many people use it specifically for anxiety, sleep, or perceived OCD relief, while evidence for treating OCD remains limited.

In an internet survey of 601 cannabis-using adults with OCD, nearly 90% described their cannabis use as medicinal and 29% reported using it specifically for OCD symptoms. Many participants perceived benefit, but 42% met criteria for cannabis use disorder, and more frequent cannabis use was associated with lower odds of receiving evidence-based OCD treatment (Kayser et al., 2021). The survey was self-selected and observational, so perceived improvement cannot establish efficacy.

A small randomized, placebo-controlled laboratory study provides a useful counterpoint. Twelve participants completed sessions involving placebo cannabis, primarily THC cannabis, and primarily CBD cannabis. Active THC or CBD did not reduce OCD symptoms more than placebo, and placebo produced a larger immediate reduction in state anxiety than the active preparations (Kayser et al., 2020). The sample was very small, so this study does not settle every cannabinoid question; it does show why expectancy and placebo control matter.

Separate observational work has linked obsessive-compulsive symptom severity with cannabis misuse and has again identified coping motives as a possible explanatory pathway (Bakhshaie et al., 2020; Spradlin et al., 2017). Taken together, the current evidence does not support presenting cannabis as an established treatment for OCD.

What About Stimulants, Opioids, Sedatives, and Other Drugs?

Different substances require different clinical questions. “Drug use” is not one mechanism. Stimulants may be used for energy, concentration, social confidence, or recreation and can affect sleep, arousal, anxiety, and repetitive thinking. Opioids have a distinct dependence and overdose profile. Sedatives may be used to suppress anxiety or insomnia but can create tolerance, dependence, cognitive impairment, and dangerous interactions, especially when combined with alcohol or opioids.

Benzodiazepines are especially important to distinguish from standard OCD treatment. They can reduce acute anxiety, but they are not a core evidence-based treatment for OCD itself, and physical dependence can develop with regular use. The 2025 multidisciplinary Joint Clinical Practice Guideline on Benzodiazepine Tapering advises that people who have been taking benzodiazepines regularly for more than a month should generally not stop abruptly; tapering should be individualized and clinically supervised.

If a person has both OCD and an opioid use disorder, evidence-based medications for OUD remain appropriate. SAMHSA identifies buprenorphine, methadone, and naltrexone as established medication options for opioid use disorder (SAMHSA Treatment Options). OCD does not make addiction treatment less legitimate, and treatment for OUD should not be withheld merely because anxiety or compulsive symptoms are also present.

Is Addiction a Compulsion Like an OCD Compulsion?

The word “compulsive” is used in both fields, which can create diagnostic confusion. At a broad behavioral level, both OCD and addiction can involve repetitive actions that continue despite costs. At the clinical level, the functions and diagnostic structures differ.

An OCD compulsion is typically performed in response to an obsession or according to a rigid rule, often to reduce distress or prevent a feared outcome. Substance use in a SUD can become repetitive through reward learning, craving, withdrawal relief, habit formation, impaired control, cue reactivity, and other addiction processes. A person can also use a substance as an OCD-related safety behavior, for example drinking before a feared social or contamination situation because intoxication makes the trigger easier to tolerate. That functional relationship matters, but it still does not transform the substance use into a diagnostic OCD compulsion by definition.

This distinction affects treatment. ERP targets the obsession-compulsion-avoidance cycle by helping a person face uncertainty and triggers while reducing ritualized responses. SUD treatment may target craving, triggers, reinforcement patterns, withdrawal, motivation, environmental contingencies, medication needs, and relapse prevention. Integrated care can address both cycles at once.

Self-Medication, Risky Use, and Substance Use Disorder Are Different

A person may say, “I drink because it is the only thing that quiets my brain.” That statement describes function, not diagnosis. Clinicians still need to ask whether the pattern involves impaired control, escalating quantity, tolerance, withdrawal, hazardous use, failed attempts to cut down, role impairment, continued use despite harm, or intense craving.

Likewise, using a substance to cope does not automatically mean a SUD is present. The clinically useful approach is to map the pattern: what happens before use, what the person expects the substance to do, what happens immediately afterward, what happens hours or days later, how control has changed over time, and what costs have accumulated.

This functional analysis can also identify an OCD loop. If a person always drinks after an intrusive thought because they believe they must neutralize the thought or cannot tolerate the resulting uncertainty, the use may be embedded in the OCD maintenance cycle. Treatment then needs to address both the substance behavior and the feared meaning attached to the obsession.

Can Substance Use Cause or Mimic OCD Symptoms?

Yes, substance effects can complicate the picture. Intoxication, withdrawal, sleep deprivation, stimulant effects, cannabis effects, and medication interactions can produce anxiety, agitation, repetitive behavior, suspiciousness, perceptual changes, or intrusive-seeming thoughts. These experiences require a careful timeline rather than a label based on one symptom.

Craving is also not the same thing as an OCD obsession. A person with addiction may think repeatedly about obtaining, using, or recovering from a substance. Those thoughts can feel intrusive and difficult to control, yet their phenomenology and relationship to reward, withdrawal, cues, and use may differ from classic OCD obsessions. Conversely, a person can have both craving and genuine OCD obsessions.

When panic-like episodes occur during intoxication, withdrawal, or OCD triggers, clinicians may also need to distinguish them from a separate panic disorder. Our guide to OCD and panic attacks explains that distinction in more detail.

How Clinicians Assess OCD and Substance Use Together

A good assessment reconstructs the timeline. Which came first: obsessions and compulsions, regular substance use, escalating use, withdrawal, mood episodes, trauma symptoms, panic, sleep disruption, or functional decline? The answer can change the differential diagnosis and the treatment sequence.

Assessment usually covers the form and content of obsessions, visible and mental compulsions, avoidance, reassurance seeking, time consumed, distress, impairment, insight, and symptom triggers. It also covers the substances used, quantity and frequency, route of administration, binge patterns, tolerance, withdrawal, craving, loss of control, overdose history, prior treatment, periods of abstinence, and the relationship between use and OCD symptoms.

Safety questions matter. Clinicians may ask about severe withdrawal history, seizures, overdose, mixing of sedatives, suicidal thoughts or behavior, psychotic symptoms, manic symptoms, medical complications, and access to emergency care. This is clinical risk assessment, not a judgment about character.

Comorbidity should also be evaluated rather than assumed. NICE OCD guidance recommends attention to depression, suicide risk, alcohol or substance misuse, and other coexisting conditions. When bipolar disorder is possible, medication decisions can require particular care; our OCD and bipolar disorder guide covers that problem separately.

Screening Is Not Diagnosis

Self-report questionnaires can help identify OCD symptoms, hazardous drinking, cannabis-related problems, or drug-related risk. They cannot by themselves determine whether a person has OCD, a SUD, both, or a substance-induced syndrome. Diagnosis requires the broader clinical pattern, including impairment, duration, context, exclusion of better explanations, and the relationship between symptoms and substance effects.

Treatment When OCD and a Substance Use Disorder Co-Occur

The strongest general principle is integrated treatment. SAMHSA recommends that people with co-occurring mental and substance use disorders be screened and treated for both conditions, with coordinated care rather than fragmented referral loops (SAMHSA, Co-Occurring Disorders and Other Health Conditions).

For OCD, exposure and response prevention (ERP), usually delivered within cognitive behavioral therapy, is a first-line psychological treatment. SSRIs are first-line pharmacological treatments, with clomipramine and augmentation strategies considered in selected cases. NICE recommends CBT with ERP and/or SSRIs according to severity, prior treatment, preference, and response (NICE CG31).

For SUD, treatment depends on the substance and the individual. It can include motivational interventions, cognitive and behavioral therapies, contingency management, recovery supports, harm-reduction strategies, and medications where evidence-based pharmacotherapy exists. For alcohol use disorder, the U.S. FDA has approved naltrexone, acamprosate, and disulfiram; for opioid use disorder, medication options include buprenorphine, methadone, and naltrexone (SAMHSA Treatment Options; NIAAA Alcohol Treatment).

Does One Disorder Have to Be Treated First?

There is no universal rule that a person must become completely substance-free before OCD treatment can begin. Medical stabilization takes priority when there is acute intoxication, dangerous withdrawal, overdose risk, delirium, or another emergency. Outside those situations, treatment planning can often be concurrent.

Direct randomized evidence specific to OCD plus SUD is limited. One older randomized study assigned 60 people with both diagnoses in a therapeutic community to integrated OCD-plus-substance treatment, substance treatment alone, or substance treatment plus relaxation. The integrated condition produced longer treatment retention, greater OCD symptom reduction, and higher overall abstinence at 12-month follow-up (Fals-Stewart & Schafer, 1992). Because the study is old and small, it should be viewed as supportive rather than definitive evidence for modern integrated protocols.

ERP Can Be Adapted to the Co-Occurring Pattern

ERP asks the person to approach feared cues, uncertainty, or intrusive thoughts while reducing compulsions and safety behaviors. When substances have become part of the safety system, the therapist may need to identify whether the person uses alcohol or drugs immediately before or after exposures to blunt distress. Exposure performed only while intoxicated may teach a different lesson from exposure performed while fully present and able to learn that anxiety and uncertainty can be tolerated.

At the same time, ERP should not be confused with deliberately provoking dangerous withdrawal, intoxication, or overdose risk. Medical stabilization and exposure learning are different clinical tasks. A coordinated OCD therapist and addiction clinician can decide how to structure exposure work around withdrawal management, recovery medication, sleep, cravings, and relapse risk.

Medication When OCD and SUD Co-Occur

Medication decisions should be individualized around the OCD presentation, the substance involved, medical history, current intoxication or withdrawal risk, other psychiatric diagnoses, and potential interactions. SSRIs remain standard evidence-based medications for OCD, but adherence and substance use can influence real-world treatment response.

The 2026 study by Samuels and colleagues is especially relevant here: OCD participants with lifetime alcohol dependence were less likely to have received serotonin reuptake inhibitors and, among those treated, were less likely to report a good response (Samuels et al., 2026). This finding cannot prove that alcohol dependence biologically caused poorer medication response; it may also reflect adherence, comorbidity, severity, access, treatment history, or other factors. It does support asking about alcohol rather than interpreting every inadequate response as “treatment-resistant OCD.”

NICE likewise advises clinicians reviewing inadequate SSRI response to confirm that the medication has been taken regularly at an adequate dose and that alcohol or substance use is not interfering with treatment (NICE CG31). Medication interaction checks are particularly important when alcohol, sedatives, opioids, stimulants, or multiple prescribed drugs are involved.

Clomipramine can be effective for OCD but has a different adverse-effect and interaction profile from SSRIs. Alcohol can worsen sedation and other medication effects. A prescriber or pharmacist should review the exact medication and substance combination rather than relying on a generic rule that all antidepressants interact with alcohol in the same way (NIAAA Alcohol-Medication Interactions).

Withdrawal Safety: When Stopping Suddenly Can Be Dangerous

“Just stop using” is not medically appropriate advice for every substance pattern. Alcohol withdrawal can become severe and can include seizures or delirium. Regular benzodiazepine use can produce physical dependence, and abrupt discontinuation can cause serious withdrawal. ASAM provides separate clinical guidance for alcohol withdrawal and benzodiazepine tapering.

Opioid withdrawal is generally managed differently from alcohol or benzodiazepine withdrawal, but opioid use carries a major overdose risk, especially after loss of tolerance or when opioids are combined with other sedating substances. Evidence-based medications for opioid use disorder reduce the need to frame recovery as an unsupported test of willpower.

What Recovery Can Look Like

Recovery is not defined by the disappearance of every intrusive thought. In OCD treatment, progress often means less ritualizing, less avoidance, greater tolerance of uncertainty, and restored functioning even when unwanted thoughts still appear. In SUD treatment, progress may include reduced or stopped use according to the treatment goal, safer behavior, improved control, medication adherence, stronger recovery supports, and fewer substance-related consequences.

When both disorders are present, improvement in one domain can make the other easier to treat. Reduced intoxication and withdrawal can improve sleep, consistency, memory, attendance, and the ability to engage in ERP. Better OCD treatment can reduce the distress that previously triggered substance-based coping. The two processes can reinforce each other without requiring a simplistic claim that one diagnosis caused the other.

How Family and Partners Can Help

Family members often see the interaction before clinicians do: drinking after contamination triggers, cannabis before leaving the house, sedatives after reassurance cycles, missed ERP sessions after binges, or escalating rituals during withdrawal. Useful support starts with describing the pattern clearly and encouraging assessment of both conditions.

It is also useful to distinguish support from accommodation. Repeatedly helping a person neutralize OCD fears can maintain the OCD cycle, while covering up dangerous substance use can delay care. Families can support treatment attendance, medication review, recovery planning, emergency safety, and consistent boundaries. Our separate guide to OCD and parenting explains family accommodation in greater detail.

When to Seek Urgent Help

Urgent medical or emergency help is appropriate for suspected overdose, loss of consciousness, severe breathing problems, seizure, severe confusion, hallucinations with dangerous behavior, severe alcohol or sedative withdrawal, or an immediate risk of suicide or serious self-harm. The exact emergency pathway depends on the country and local health system.

Someone who is physically dependent on alcohol or benzodiazepines should not use an internet article as a withdrawal plan. Clinical assessment is the safer route because withdrawal risk depends on dose, duration, prior withdrawal, other substances, medical history, and current symptoms.

Frequently Asked Questions

Can OCD Cause Addiction?

OCD can contribute to conditions in which substance use becomes appealing, especially when alcohol or drugs are used to escape intrusive thoughts, anxiety, insomnia, shame, or distress. Research also points to shared genetic and behavioral vulnerabilities. That does not establish a universal causal pathway from OCD to addiction. Many people with OCD never develop a substance use disorder.

Do People With OCD Drink More Alcohol?

Some OCD samples show elevated rates of alcohol use disorder or dependence, but the answer depends on what is measured. A 2026 OCD cohort found lifetime DSM-IV alcohol dependence in 13% of 1,222 participants, while other clinical samples have produced different estimates. The most useful clinical question is not whether “people with OCD drink more” in the abstract, but whether a specific person’s drinking is becoming hazardous, compulsive, dependent, or functionally impairing.

Can Alcohol Make OCD Worse?

It can. Alcohol may produce short-term relief while worsening sleep, mood, judgment, adherence, withdrawal-related anxiety, and reliance on avoidance. Effects vary by person and pattern of use. Alcohol can also interact with psychiatric and other medications.

Can Cannabis Help OCD?

Cannabis is not an established evidence-based OCD treatment. Survey participants with OCD often report subjective benefits, but a small placebo-controlled laboratory study did not find THC- or CBD-dominant cannabis superior to placebo for acute OCD symptoms. Cannabis use disorder can also occur in people who use cannabis for perceived symptom relief.

Is Substance Use an OCD Compulsion?

Not automatically. Substance use can become linked to an OCD trigger or function as a safety behavior, but SUD and OCD are distinct clinical disorders with different diagnostic criteria and treatment targets. A functional assessment can determine how the behaviors interact.

Can Withdrawal Cause Intrusive Thoughts or Anxiety?

Withdrawal can produce anxiety, insomnia, agitation, dysphoria, perceptual changes, and intense preoccupation with obtaining a substance. Those experiences can resemble or amplify OCD distress. A clinician may need to assess symptoms after stabilization and reconstruct the timeline to distinguish persistent OCD from substance-related effects.

Can ERP Be Used if Someone Has a Substance Use Disorder?

Often yes, with coordination and appropriate medical safety. Acute intoxication, dangerous withdrawal, or unstable medical risk may require stabilization first. Once safe, ERP can be integrated with SUD treatment rather than automatically postponed until an arbitrary period of perfect abstinence.

Can Someone Take SSRIs for OCD While in Addiction Treatment?

Often yes. SSRIs are standard OCD treatments, and SUD treatment does not automatically exclude them. The prescriber should review the specific substance, recovery medications, medical conditions, interactions, adherence, and co-occurring psychiatric diagnoses.

Should OCD or Addiction Be Treated First?

Medical emergencies come first. Outside acute safety situations, coordinated treatment of both conditions is often preferable to forcing a rigid sequence. The balance depends on withdrawal risk, severity, the substances involved, motivation, access to care, and whether substance use is interfering with ERP or medication.

What Should I Tell a Clinician?

Be specific about both symptom systems: what your intrusive thoughts are like, what rituals or avoidance you use, which substances you take, how often and how much, what happens when you stop, what you are trying to feel or avoid when you use, and how use affects treatment. A precise timeline is often more diagnostically useful than trying to decide the label yourself.

Key Takeaway

OCD and substance use disorders can co-occur through several pathways, including coping, reinforcement, shared vulnerability, and the influence of other psychiatric conditions. The overlap is clinically significant without making the disorders interchangeable. Alcohol or drugs may temporarily change how distress feels, but temporary relief can coexist with dependence, withdrawal, treatment interference, or increased risk.

The strongest treatment logic is coordinated: identify what is OCD, what is substance-related, what is another comorbid condition, what requires immediate medical attention, and which evidence-based treatments address each part of the pattern. ERP and established OCD medications can be combined with evidence-based SUD treatment, including addiction-focused behavioral care and medications for alcohol or opioid use disorder when indicated.

References

American Society of Addiction Medicine. (2020). The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. https://www.asam.org/quality-care/clinical-guidelines/alcohol-withdrawal-management-guideline

American Society of Addiction Medicine and partner organizations. (2025). Joint Clinical Practice Guideline on Benzodiazepine Tapering. https://www.asam.org/quality-care/clinical-guidelines/benzodiazepine-tapering

Bakhshaie, J., Storch, E. A., Tran, N., & Zvolensky, M. J. (2020). Obsessive-compulsive symptoms and cannabis misuse: The explanatory role of cannabis use motives. Journal of Dual Diagnosis, 16(4), 409–419. https://doi.org/10.1080/15504263.2020.1786616

Bakhshaie, J., Storch, E. A., & Zvolensky, M. J. (2021). Obsessive-compulsive symptoms and problematic alcohol use: The explanatory role of drinking motives. Addictive Behaviors, 115, 106734. https://doi.org/10.1016/j.addbeh.2020.106734

Blom, R. M., Koeter, M., van den Brink, W., de Graaf, R., ten Have, M., & Denys, D. (2011). Co-occurrence of obsessive-compulsive disorder and substance use disorder in the general population. Addiction, 106(12), 2178–2185. https://doi.org/10.1111/j.1360-0443.2011.03559.x

Cuzen, N. L., Stein, D. J., Lochner, C., & Fineberg, N. A. (2014). Comorbidity of obsessive-compulsive disorder and substance use disorder: A new heuristic. Human Psychopharmacology, 29(1), 89–93. https://doi.org/10.1002/hup.2373

Fals-Stewart, W., & Schafer, J. (1992). The treatment of substance abusers diagnosed with obsessive-compulsive disorder: An outcome study. Journal of Substance Abuse Treatment, 9(4), 365–370. https://doi.org/10.1016/0740-5472(92)90032-J

Gentil, A. F., de Mathis, M. A., Torresan, R. C., Diniz, J. B., Alvarenga, P., do Rosário, M. C., Cordioli, A. V., Torres, A. R., & Miguel, E. C. (2009). Alcohol use disorders in patients with obsessive-compulsive disorder: The importance of appropriate dual-diagnosis. Drug and Alcohol Dependence, 100(1–2), 173–177. https://doi.org/10.1016/j.drugalcdep.2008.09.010

Kayser, R. R., Haney, M., Raskin, M., Arout, C., & Simpson, H. B. (2020). Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study. Depression and Anxiety, 37(8), 801–811. https://doi.org/10.1002/da.23032

Kayser, R. R., Senter, M. S., Tobet, R., Raskin, M., Patel, S., & Simpson, H. B. (2021). Patterns of cannabis use among individuals with obsessive-compulsive disorder: Results from an internet survey. Journal of Obsessive-Compulsive and Related Disorders, 30, 100664. https://doi.org/10.1016/j.jocrd.2021.100664

Mancebo, M. C., Grant, J. E., Pinto, A., Eisen, J. L., & Rasmussen, S. A. (2009). Substance use disorders in an obsessive compulsive disorder clinical sample. Journal of Anxiety Disorders, 23(4), 429–435. https://doi.org/10.1016/j.janxdis.2008.08.008

National Institute for Health and Care Excellence. (2005, current recommendations). Obsessive-compulsive disorder and body dysmorphic disorder: treatment. Clinical guideline CG31. https://www.nice.org.uk/guidance/cg31/chapter/Recommendations

National Institute of Mental Health. Obsessive-Compulsive Disorder: When Unwanted Thoughts or Repetitive Behaviors Take Over. https://www.nimh.nih.gov/health/publications/obsessive-compulsive-disorder-when-unwanted-thoughts-or-repetitive-behaviors-take-over

National Institute on Alcohol Abuse and Alcoholism. Alcohol-Medication Interactions: Potentially Dangerous Mixes. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/alcohol-medication-interactions-potentially-dangerous-mixes

National Institute on Alcohol Abuse and Alcoholism. Treatment for Alcohol Problems: Finding and Getting Help. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/treatment-alcohol-problems-finding-and-getting-help

Randazza, M. P., Ham, L. S., & McKay, D. (2024). An analysis of drinking motives in the maintenance of co-occurring obsessive-compulsive symptoms and alcohol misuse. Substance Use & Misuse, 59(14), 2073–2083. https://doi.org/10.1080/10826084.2024.2392558

Samuels, J., Bienvenu, O. J., Krasnow, J., Grados, M. A., Cullen, B. A., Goes, F. S., et al. (2026). A study of alcohol dependence in obsessive-compulsive disorder. Journal of Psychiatric Research, 198, 258–264. https://doi.org/10.1016/j.jpsychires.2026.04.003

Spradlin, A., Mauzay, D., & Cuttler, C. (2017). Symptoms of obsessive-compulsive disorder predict cannabis misuse. Addictive Behaviors, 72, 159–164. https://doi.org/10.1016/j.addbeh.2017.03.023

Substance Abuse and Mental Health Services Administration. Co-Occurring Disorders and Other Health Conditions. https://www.samhsa.gov/substance-use/treatment/co-occurring-disorders

Substance Abuse and Mental Health Services Administration. Treatment Options for Substance Use Disorder. https://www.samhsa.gov/substance-use/treatment/options

Virtanen, S., Kuja-Halkola, R., Sidorchuk, A., Fernández de la Cruz, L., Rück, C., Lundström, S., et al. (2022). Association of obsessive-compulsive disorder and obsessive-compulsive symptoms with substance misuse in 2 longitudinal cohorts in Sweden. JAMA Network Open, 5(6), e2214779. https://doi.org/10.1001/jamanetworkopen.2022.14779

Психологічна енкциклопедія